Loading…

Research progress on the roles of dopamine and dopamine receptors in digestive system diseases

Dopamine (DA) is a neurotransmitter synthesized in the human body that acts on multiple organs throughout the body, reaching them through the blood circulation. Neurotransmitters are special molecules that act as messengers by binding to receptors at chemical synapses between neurons. As ligands, th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular and molecular medicine 2024-04, Vol.28 (7), p.e18154-n/a
Main Authors: Lu, Xianmin, Liu, Qi, Deng, Ya, Wu, Jiangbo, Mu, Xingyi, Yang, Xiaoxu, Zhang, Ting, Luo, Chen, Li, Zhuo, Tang, Siqi, Hu, Yanxia, Du, Qian, Xu, Jingyu, Xie, Rui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4084-162dc547ecafa15d35bf5a6aa05eca8a5ebb9522a77d91fda19bcdaf5a2c35f63
container_end_page n/a
container_issue 7
container_start_page e18154
container_title Journal of cellular and molecular medicine
container_volume 28
creator Lu, Xianmin
Liu, Qi
Deng, Ya
Wu, Jiangbo
Mu, Xingyi
Yang, Xiaoxu
Zhang, Ting
Luo, Chen
Li, Zhuo
Tang, Siqi
Hu, Yanxia
Du, Qian
Xu, Jingyu
Xie, Rui
description Dopamine (DA) is a neurotransmitter synthesized in the human body that acts on multiple organs throughout the body, reaching them through the blood circulation. Neurotransmitters are special molecules that act as messengers by binding to receptors at chemical synapses between neurons. As ligands, they mainly bind to corresponding receptors on central or peripheral tissue cells. Signalling through chemical synapses is involved in regulating the activities of various body systems. Lack of DA or a decrease in DA levels in the brain can lead to serious diseases such as Parkinson's disease, schizophrenia, addiction and attention deficit disorder. It is widely recognized that DA is closely related to neurological diseases. As research on the roles of brain‐gut peptides in human physiology and pathology has deepened in recent years, the regulatory role of neurotransmitters in digestive system diseases has gradually attracted researchers' attention, and research on DA has expanded to the field of digestive system diseases. This review mainly elaborates on the research progress on the roles of DA and DRs related to digestive system diseases. Starting from the biochemical and pharmacological properties of DA and DRs, it discusses the therapeutic value of DA‐ and DR‐related drugs for digestive system diseases.
doi_str_mv 10.1111/jcmm.18154
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10945074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2967057484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4084-162dc547ecafa15d35bf5a6aa05eca8a5ebb9522a77d91fda19bcdaf5a2c35f63</originalsourceid><addsrcrecordid>eNp9kU9PGzEQxa2qVaHApR8AWeoFIQXstb1_ThWKoIBAlSp6xZq1ZxNHu-vF3oDy7XFICm0P-GLP-KenN_MI-crZCU_ndGG67oSXXMkPZJerMpvISsiP2zcvRblDvsS4YEzkXFSfyY4oZSVLyXbJ_S-MCMHM6RD8LGCM1Pd0nCMNvsVUNNT6ATrXI4XevhUBDQ6jD5G6nlo3wzi6R6RxFUfsUiOpRoz75FMDbcSD7b1Hfl-c300vJzc_f1xNz24mRrJSTnieWaNkgQYa4MoKVTcKcgCmUqsEhXVdqSyDorAVbyzwqjYWEpMZoZpc7JHvG91hWXdoDfZjgFYPwXUQVtqD0__-9G6uZ_5Rc1ZJxQqZFI62CsE_LNM0unPRYNtCj34ZdVblBVNF2lpCv_2HLvwy9Gm-RBVCSJnna0vHG8oEH2PA5tUNZ3qdm17npl9yS_Dh3_5f0T9BJYBvgCfX4uodKX09vb3diD4DegOl-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2973344666</pqid></control><display><type>article</type><title>Research progress on the roles of dopamine and dopamine receptors in digestive system diseases</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Lu, Xianmin ; Liu, Qi ; Deng, Ya ; Wu, Jiangbo ; Mu, Xingyi ; Yang, Xiaoxu ; Zhang, Ting ; Luo, Chen ; Li, Zhuo ; Tang, Siqi ; Hu, Yanxia ; Du, Qian ; Xu, Jingyu ; Xie, Rui</creator><creatorcontrib>Lu, Xianmin ; Liu, Qi ; Deng, Ya ; Wu, Jiangbo ; Mu, Xingyi ; Yang, Xiaoxu ; Zhang, Ting ; Luo, Chen ; Li, Zhuo ; Tang, Siqi ; Hu, Yanxia ; Du, Qian ; Xu, Jingyu ; Xie, Rui</creatorcontrib><description>Dopamine (DA) is a neurotransmitter synthesized in the human body that acts on multiple organs throughout the body, reaching them through the blood circulation. Neurotransmitters are special molecules that act as messengers by binding to receptors at chemical synapses between neurons. As ligands, they mainly bind to corresponding receptors on central or peripheral tissue cells. Signalling through chemical synapses is involved in regulating the activities of various body systems. Lack of DA or a decrease in DA levels in the brain can lead to serious diseases such as Parkinson's disease, schizophrenia, addiction and attention deficit disorder. It is widely recognized that DA is closely related to neurological diseases. As research on the roles of brain‐gut peptides in human physiology and pathology has deepened in recent years, the regulatory role of neurotransmitters in digestive system diseases has gradually attracted researchers' attention, and research on DA has expanded to the field of digestive system diseases. This review mainly elaborates on the research progress on the roles of DA and DRs related to digestive system diseases. Starting from the biochemical and pharmacological properties of DA and DRs, it discusses the therapeutic value of DA‐ and DR‐related drugs for digestive system diseases.</description><identifier>ISSN: 1582-1838</identifier><identifier>ISSN: 1582-4934</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.18154</identifier><identifier>PMID: 38494840</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Addictions ; Adenosine ; Blood circulation ; Blood vessels ; Brain research ; brain‐gut axis ; Digestive system ; Digestive System Diseases ; Dopamine ; Dopamine - metabolism ; dopamine receptor ; Dopamine receptors ; Esophageal cancer ; Gastric cancer ; Gastroesophageal reflux ; Humans ; Liver cancer ; Medical prognosis ; Mental disorders ; Metastasis ; Microbiota ; Movement disorders ; Nervous system ; Neurodegenerative diseases ; Neurological diseases ; neurotransmitter ; Neurotransmitter Agents ; Neurotransmitters ; Pancreatic cancer ; Parkinson Disease - metabolism ; Parkinson's disease ; Physiology ; Proteins ; Receptors, Dopamine ; Review ; Reviews ; Schizophrenia ; Small intestine ; Synapses ; Ulcers</subject><ispartof>Journal of cellular and molecular medicine, 2024-04, Vol.28 (7), p.e18154-n/a</ispartof><rights>2024 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</rights><rights>2024 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4084-162dc547ecafa15d35bf5a6aa05eca8a5ebb9522a77d91fda19bcdaf5a2c35f63</cites><orcidid>0000-0001-7926-6431 ; 0000-0002-6101-4348 ; 0000-0002-0545-0444</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2973344666/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2973344666?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38494840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Xianmin</creatorcontrib><creatorcontrib>Liu, Qi</creatorcontrib><creatorcontrib>Deng, Ya</creatorcontrib><creatorcontrib>Wu, Jiangbo</creatorcontrib><creatorcontrib>Mu, Xingyi</creatorcontrib><creatorcontrib>Yang, Xiaoxu</creatorcontrib><creatorcontrib>Zhang, Ting</creatorcontrib><creatorcontrib>Luo, Chen</creatorcontrib><creatorcontrib>Li, Zhuo</creatorcontrib><creatorcontrib>Tang, Siqi</creatorcontrib><creatorcontrib>Hu, Yanxia</creatorcontrib><creatorcontrib>Du, Qian</creatorcontrib><creatorcontrib>Xu, Jingyu</creatorcontrib><creatorcontrib>Xie, Rui</creatorcontrib><title>Research progress on the roles of dopamine and dopamine receptors in digestive system diseases</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Dopamine (DA) is a neurotransmitter synthesized in the human body that acts on multiple organs throughout the body, reaching them through the blood circulation. Neurotransmitters are special molecules that act as messengers by binding to receptors at chemical synapses between neurons. As ligands, they mainly bind to corresponding receptors on central or peripheral tissue cells. Signalling through chemical synapses is involved in regulating the activities of various body systems. Lack of DA or a decrease in DA levels in the brain can lead to serious diseases such as Parkinson's disease, schizophrenia, addiction and attention deficit disorder. It is widely recognized that DA is closely related to neurological diseases. As research on the roles of brain‐gut peptides in human physiology and pathology has deepened in recent years, the regulatory role of neurotransmitters in digestive system diseases has gradually attracted researchers' attention, and research on DA has expanded to the field of digestive system diseases. This review mainly elaborates on the research progress on the roles of DA and DRs related to digestive system diseases. Starting from the biochemical and pharmacological properties of DA and DRs, it discusses the therapeutic value of DA‐ and DR‐related drugs for digestive system diseases.</description><subject>Addictions</subject><subject>Adenosine</subject><subject>Blood circulation</subject><subject>Blood vessels</subject><subject>Brain research</subject><subject>brain‐gut axis</subject><subject>Digestive system</subject><subject>Digestive System Diseases</subject><subject>Dopamine</subject><subject>Dopamine - metabolism</subject><subject>dopamine receptor</subject><subject>Dopamine receptors</subject><subject>Esophageal cancer</subject><subject>Gastric cancer</subject><subject>Gastroesophageal reflux</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Mental disorders</subject><subject>Metastasis</subject><subject>Microbiota</subject><subject>Movement disorders</subject><subject>Nervous system</subject><subject>Neurodegenerative diseases</subject><subject>Neurological diseases</subject><subject>neurotransmitter</subject><subject>Neurotransmitter Agents</subject><subject>Neurotransmitters</subject><subject>Pancreatic cancer</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson's disease</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Receptors, Dopamine</subject><subject>Review</subject><subject>Reviews</subject><subject>Schizophrenia</subject><subject>Small intestine</subject><subject>Synapses</subject><subject>Ulcers</subject><issn>1582-1838</issn><issn>1582-4934</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp9kU9PGzEQxa2qVaHApR8AWeoFIQXstb1_ThWKoIBAlSp6xZq1ZxNHu-vF3oDy7XFICm0P-GLP-KenN_MI-crZCU_ndGG67oSXXMkPZJerMpvISsiP2zcvRblDvsS4YEzkXFSfyY4oZSVLyXbJ_S-MCMHM6RD8LGCM1Pd0nCMNvsVUNNT6ATrXI4XevhUBDQ6jD5G6nlo3wzi6R6RxFUfsUiOpRoz75FMDbcSD7b1Hfl-c300vJzc_f1xNz24mRrJSTnieWaNkgQYa4MoKVTcKcgCmUqsEhXVdqSyDorAVbyzwqjYWEpMZoZpc7JHvG91hWXdoDfZjgFYPwXUQVtqD0__-9G6uZ_5Rc1ZJxQqZFI62CsE_LNM0unPRYNtCj34ZdVblBVNF2lpCv_2HLvwy9Gm-RBVCSJnna0vHG8oEH2PA5tUNZ3qdm17npl9yS_Dh3_5f0T9BJYBvgCfX4uodKX09vb3diD4DegOl-w</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Lu, Xianmin</creator><creator>Liu, Qi</creator><creator>Deng, Ya</creator><creator>Wu, Jiangbo</creator><creator>Mu, Xingyi</creator><creator>Yang, Xiaoxu</creator><creator>Zhang, Ting</creator><creator>Luo, Chen</creator><creator>Li, Zhuo</creator><creator>Tang, Siqi</creator><creator>Hu, Yanxia</creator><creator>Du, Qian</creator><creator>Xu, Jingyu</creator><creator>Xie, Rui</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7926-6431</orcidid><orcidid>https://orcid.org/0000-0002-6101-4348</orcidid><orcidid>https://orcid.org/0000-0002-0545-0444</orcidid></search><sort><creationdate>202404</creationdate><title>Research progress on the roles of dopamine and dopamine receptors in digestive system diseases</title><author>Lu, Xianmin ; Liu, Qi ; Deng, Ya ; Wu, Jiangbo ; Mu, Xingyi ; Yang, Xiaoxu ; Zhang, Ting ; Luo, Chen ; Li, Zhuo ; Tang, Siqi ; Hu, Yanxia ; Du, Qian ; Xu, Jingyu ; Xie, Rui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4084-162dc547ecafa15d35bf5a6aa05eca8a5ebb9522a77d91fda19bcdaf5a2c35f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Addictions</topic><topic>Adenosine</topic><topic>Blood circulation</topic><topic>Blood vessels</topic><topic>Brain research</topic><topic>brain‐gut axis</topic><topic>Digestive system</topic><topic>Digestive System Diseases</topic><topic>Dopamine</topic><topic>Dopamine - metabolism</topic><topic>dopamine receptor</topic><topic>Dopamine receptors</topic><topic>Esophageal cancer</topic><topic>Gastric cancer</topic><topic>Gastroesophageal reflux</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Mental disorders</topic><topic>Metastasis</topic><topic>Microbiota</topic><topic>Movement disorders</topic><topic>Nervous system</topic><topic>Neurodegenerative diseases</topic><topic>Neurological diseases</topic><topic>neurotransmitter</topic><topic>Neurotransmitter Agents</topic><topic>Neurotransmitters</topic><topic>Pancreatic cancer</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson's disease</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Receptors, Dopamine</topic><topic>Review</topic><topic>Reviews</topic><topic>Schizophrenia</topic><topic>Small intestine</topic><topic>Synapses</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Xianmin</creatorcontrib><creatorcontrib>Liu, Qi</creatorcontrib><creatorcontrib>Deng, Ya</creatorcontrib><creatorcontrib>Wu, Jiangbo</creatorcontrib><creatorcontrib>Mu, Xingyi</creatorcontrib><creatorcontrib>Yang, Xiaoxu</creatorcontrib><creatorcontrib>Zhang, Ting</creatorcontrib><creatorcontrib>Luo, Chen</creatorcontrib><creatorcontrib>Li, Zhuo</creatorcontrib><creatorcontrib>Tang, Siqi</creatorcontrib><creatorcontrib>Hu, Yanxia</creatorcontrib><creatorcontrib>Du, Qian</creatorcontrib><creatorcontrib>Xu, Jingyu</creatorcontrib><creatorcontrib>Xie, Rui</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley Free Archive</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Xianmin</au><au>Liu, Qi</au><au>Deng, Ya</au><au>Wu, Jiangbo</au><au>Mu, Xingyi</au><au>Yang, Xiaoxu</au><au>Zhang, Ting</au><au>Luo, Chen</au><au>Li, Zhuo</au><au>Tang, Siqi</au><au>Hu, Yanxia</au><au>Du, Qian</au><au>Xu, Jingyu</au><au>Xie, Rui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research progress on the roles of dopamine and dopamine receptors in digestive system diseases</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2024-04</date><risdate>2024</risdate><volume>28</volume><issue>7</issue><spage>e18154</spage><epage>n/a</epage><pages>e18154-n/a</pages><issn>1582-1838</issn><issn>1582-4934</issn><eissn>1582-4934</eissn><abstract>Dopamine (DA) is a neurotransmitter synthesized in the human body that acts on multiple organs throughout the body, reaching them through the blood circulation. Neurotransmitters are special molecules that act as messengers by binding to receptors at chemical synapses between neurons. As ligands, they mainly bind to corresponding receptors on central or peripheral tissue cells. Signalling through chemical synapses is involved in regulating the activities of various body systems. Lack of DA or a decrease in DA levels in the brain can lead to serious diseases such as Parkinson's disease, schizophrenia, addiction and attention deficit disorder. It is widely recognized that DA is closely related to neurological diseases. As research on the roles of brain‐gut peptides in human physiology and pathology has deepened in recent years, the regulatory role of neurotransmitters in digestive system diseases has gradually attracted researchers' attention, and research on DA has expanded to the field of digestive system diseases. This review mainly elaborates on the research progress on the roles of DA and DRs related to digestive system diseases. Starting from the biochemical and pharmacological properties of DA and DRs, it discusses the therapeutic value of DA‐ and DR‐related drugs for digestive system diseases.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38494840</pmid><doi>10.1111/jcmm.18154</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7926-6431</orcidid><orcidid>https://orcid.org/0000-0002-6101-4348</orcidid><orcidid>https://orcid.org/0000-0002-0545-0444</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1582-1838
ispartof Journal of cellular and molecular medicine, 2024-04, Vol.28 (7), p.e18154-n/a
issn 1582-1838
1582-4934
1582-4934
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10945074
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access; PubMed Central
subjects Addictions
Adenosine
Blood circulation
Blood vessels
Brain research
brain‐gut axis
Digestive system
Digestive System Diseases
Dopamine
Dopamine - metabolism
dopamine receptor
Dopamine receptors
Esophageal cancer
Gastric cancer
Gastroesophageal reflux
Humans
Liver cancer
Medical prognosis
Mental disorders
Metastasis
Microbiota
Movement disorders
Nervous system
Neurodegenerative diseases
Neurological diseases
neurotransmitter
Neurotransmitter Agents
Neurotransmitters
Pancreatic cancer
Parkinson Disease - metabolism
Parkinson's disease
Physiology
Proteins
Receptors, Dopamine
Review
Reviews
Schizophrenia
Small intestine
Synapses
Ulcers
title Research progress on the roles of dopamine and dopamine receptors in digestive system diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A28%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20progress%20on%20the%20roles%20of%20dopamine%20and%20dopamine%20receptors%20in%20digestive%20system%20diseases&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Lu,%20Xianmin&rft.date=2024-04&rft.volume=28&rft.issue=7&rft.spage=e18154&rft.epage=n/a&rft.pages=e18154-n/a&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.18154&rft_dat=%3Cproquest_pubme%3E2967057484%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4084-162dc547ecafa15d35bf5a6aa05eca8a5ebb9522a77d91fda19bcdaf5a2c35f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2973344666&rft_id=info:pmid/38494840&rfr_iscdi=true